Previous reports have shown other in vivo actions of Cavtratin targeting inflammation, tumor progression and right ventricle hypertrophy [24]; [25]; [39], We provide evidence showing that Cav-1 might act as a novel stabilizing factor in human atherosclerosis. This evidence concerns the gene CAV1 and neoplasm.